Emerging targeted agents in the field of mastocytosis

0 Views
administrator
administrator
07/09/23

Tracy George, MD, The University of Utah, Salt Lake City, UT, outlines the current treatment landscape of systemic mastocytosis as well as emerging agents in this field, including novel anti-KIT approaches currently in evaluation in this patient population. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Show more
0 Comments Sort By

    No comments found

    Facebook Comments

    Up next

    Lichen Amyloidosis Treatment: Moisturizer + Keratolytic Agents + Exosomes x 1 เธฃเธฑเธเธฉเธฒเน‚เธฃเธ„เธœเธดเธงเธซเธ™เธฑเธ‡
    00:00:06
    Lichen Amyloidosis Treatment: Moisturizer + Keratolytic Agents + Exosomes x 1 เธฃเธฑเธเธฉเธฒเน‚เธฃเธ„เธœเธดเธงเธซเธ™เธฑเธ‡
    administrator
    1 Views
    Emerging from the Shadows โ€” ATTR Amyloidosis Ireland
    00:08:00
    Emerging from the Shadows โ€” ATTR Amyloidosis Ireland
    administrator
    4 Views
    Lichen Amyloidosis Treatment: Moisturizer + Keratolytic Agents + Exosomes x 1 เธฃเธฑเธเธฉเธฒเน‚เธฃเธ„เธœเธดเธงเธซเธ™เธฑเธ‡
    00:00:06
    Lichen Amyloidosis Treatment: Moisturizer + Keratolytic Agents + Exosomes x 1 เธฃเธฑเธเธฉเธฒเน‚เธฃเธ„เธœเธดเธงเธซเธ™เธฑเธ‡
    administrator
    2 Views
    Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
    00:02:30
    Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
    administrator
    4 Views
    Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer
    00:51:47
    Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer
    administrator
    4 Views
    Promising new treatments for sarcomas: immunotherapy and fusion targeted compounds
    00:07:40
    Promising new treatments for sarcomas: immunotherapy and fusion targeted compounds
    administrator
    3 Views
    GESR-CME: Prof. Dr. med. Chalid Assaf (Dermatology), Emerging drugs for cutaneous T-cell lymphoma
    00:46:31
    GESR-CME: Prof. Dr. med. Chalid Assaf (Dermatology), Emerging drugs for cutaneous T-cell lymphoma
    administrator
    2 Views
    Targeted Antibody Mogamulizumab Superior to Vorinostat for Previously Treated CTCL
    00:07:09
    Targeted Antibody Mogamulizumab Superior to Vorinostat for Previously Treated CTCL
    administrator
    1 Views
    Combining targeted agents with checkpoint inhibitors in cutaneous T-cell lymphoma
    00:01:33
    Combining targeted agents with checkpoint inhibitors in cutaneous T-cell lymphoma
    administrator
    2 Views
    2022 New + Emerging Treatments: Childhood Acute Lymphocytic Leukemia
    00:52:52
    2022 New + Emerging Treatments: Childhood Acute Lymphocytic Leukemia
    administrator
    2 Views
    Emerging Strategies in the Treatment of Acute Lymphoblastic Leukemia
    00:13:22
    Emerging Strategies in the Treatment of Acute Lymphoblastic Leukemia
    administrator
    3 Views
    2022 New + Emerging Treatments: Childhood Acute Lymphocytic Leukemia
    00:52:52
    2022 New + Emerging Treatments: Childhood Acute Lymphocytic Leukemia
    administrator
    2 Views
    2022 New + Emerging Treatments: Adult Acute Lymphocytic Leukemia
    00:52:45
    2022 New + Emerging Treatments: Adult Acute Lymphocytic Leukemia
    administrator
    1 Views
    Let's talk genomics with experts | Genomic profiling and targeted therapy in Sarcoma
    01:02:10
    Let's talk genomics with experts | Genomic profiling and targeted therapy in Sarcoma
    administrator
    1 Views
    Advances in Targeted Therapies for Lung Cancer
    00:43:28
    Advances in Targeted Therapies for Lung Cancer
    administrator
    2 Views
    Advances in Targeted Therapies for Lung Cancer - by Alice T. Shaw, MD PhD
    00:43:28
    Advances in Targeted Therapies for Lung Cancer - by Alice T. Shaw, MD PhD
    administrator
    2 Views
    What targeted therapies are used for people with the ALK mutation?
    00:01:05
    What targeted therapies are used for people with the ALK mutation?
    administrator
    3 Views
    ALK and ROS1 in Lung Cancer Next Generation Targeted Therapies
    00:40:53
    ALK and ROS1 in Lung Cancer Next Generation Targeted Therapies
    administrator
    1 Views
    BRAF Targeted Therapy - Melanoma Education Symposium, Peter Boasberg MD
    00:22:44
    BRAF Targeted Therapy - Melanoma Education Symposium, Peter Boasberg MD
    administrator
    3 Views